How do pediatric patients perceive adverse drug events of anticonvulsant drugs? A survey

被引:6
作者
Neininger, Martina Patrizia [1 ,2 ]
Woltermann, Sarah [1 ,2 ,3 ]
Jeschke, Sarah [4 ]
Herziger, Birthe [4 ]
Mueller, Ruth Melinda [4 ]
Kiess, Wieland [3 ]
Bertsche, Thilo [1 ,2 ]
Bertsche, Astrid [3 ,4 ]
机构
[1] Univ Leipzig, Med Fac, Inst Pharm, Drug Safety Ctr, Bruderstr 32, D-04103 Leipzig, Germany
[2] Univ Leipzig, Med Fac, Inst Pharm, Clin Pharm, Bruderstr 32, D-04103 Leipzig, Germany
[3] Univ Hosp Children & Adolescents, Ctr Pediat Res, Liebigstr 20a, D-04103 Leipzig, Germany
[4] Univ Hosp Children & Adolescents, Neuropaediat, Ernst Heydemann Str 8, D-18057 Rostock, Germany
关键词
Adverse drug events (ADEs); Anticonvulsants; Children; Adolescents; Perceptions; Interview; SUDDEN UNEXPECTED DEATH; QUALITY-OF-LIFE; ANTIEPILEPTIC DRUGS; WEIGHT-GAIN; EPILEPSY; CHILDREN; ADOLESCENTS; OXCARBAZEPINE; VALPROATE; FEAR;
D O I
10.1007/s00431-020-03571-1
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Anticonvulsant drugs have a high risk of adverse drug events. Little is known about the perception of those events by pediatric patients. We performed a survey in the neuropediatric departments of two university hospitals. Using a questionnaire, we interviewed patients aged 6-18 years with current anticonvulsant treatment regarding (i) their fears about potential adverse drug events, (ii) experienced adverse drug events, and (iii) perceived burden of experienced adverse drug events. One hundred patients took part in the interview. (i) 40 (40%) expressed fears that the medication could harm them. Eighteen of 40 (45%) named fears concerning specific adverse drug events. Of those, 12/18 (67%) feared neurologic or psychiatric symptoms. (ii) 37 (37%) of children described altogether 60 experienced adverse drug events. Of those, 38 (63%) concerned neurologic or psychiatric symptoms. (iii) 32/37 (82%) children who experienced adverse drug events felt bothered by the experienced event. Among others, they described an emotional burden (11/37, 30%), and restrictions in school performance (8/37, 22%) and favorite leisure activities (4/37, 11%). Conclusion: School-aged children are well able to describe adverse drug events of their anticonvulsant medication. Almost two thirds of the described events concern neurologic or psychiatric symptoms that cause an emotional burden and restrictions according to the patients. What is Known: center dot Anticonvulsants have a high potential of adverse drug events. center dot In an earlier survey, parents expressed fears of severe adverse drug events such as liver failure, which seldom occur, and reported a high number of neurological and psychological adverse drug events. What is New: center dot Many children fear that their anticonvulsants could harm them, and they fear and experience neurological and psychological adverse drug events. center dot According to the children, adverse drug events cause an emotional burden and restrictions in school performance and favorite leisure activities.
引用
收藏
页码:1413 / 1420
页数:8
相关论文
共 50 条
  • [21] Do no harm - But first we need to know more: The case of adverse drug reactions with antiepileptic drugs
    Singh, Gagandeep
    NEUROLOGY INDIA, 2011, 59 (01) : 53 - 58
  • [22] Adverse effects & drug load of antiepileptic drugs in patients with epilepsy: Monotherapy versus polytherapy
    Joshi, Rupa
    Tripathi, Manjari
    Gupta, Pooja
    Gulati, Sheffali
    Gupta, Yogendra Kumar
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2017, 145 : 317 - 326
  • [23] Survey of adverse drug reactions on a pediatric ward: A strategy for early and detailed detection
    Weiss, J
    Krebs, S
    Hoffmann, C
    Werner, U
    Neubert, A
    Brune, K
    Rascher, W
    PEDIATRICS, 2002, 110 (02) : 254 - 257
  • [24] AMBULANCE PERSONNEL PERCEPTIONS OF NEAR MISSES AND ADVERSE EVENTS IN PEDIATRIC PATIENTS
    Cushman, Jeremy T.
    Fairbanks, Rollin J.
    O'Gara, Kevin G.
    Crittenden, Crista N.
    Pennington, Elliot C.
    Wilson, Matthew A.
    Chin, Nancy P.
    Shah, Manish N.
    PREHOSPITAL EMERGENCY CARE, 2010, 14 (04) : 477 - 484
  • [25] Prevention of Acute Adverse Events Related to Infliximab Infusions in Pediatric Patients
    Lahdenne, P.
    Wikstrom, A. M.
    Aalto, K.
    Kolho, K. L.
    ARTHRITIS CARE & RESEARCH, 2010, 62 (06) : 785 - 790
  • [26] Evaluation of voriconazole related adverse events in pediatric patients with hematological malignancies
    Ertem, Ozge
    Tufekci, Ozlem
    Oren, Hale
    Tuncok, Yesim
    Ergon, Mahmut Cem
    Gumustekin, Mukaddes
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (04) : 861 - 873
  • [27] Adverse Events During Supervised Exercise Interventions in Pediatric Oncology-A Nationwide Survey
    Gauss, Gabriele
    Beller, Ronja
    Boos, Joachim
    Daeggelmann, Julia
    Stalf, Hannah
    Wiskemann, Joachim
    Goette, Miriam
    FRONTIERS IN PEDIATRICS, 2021, 9
  • [28] Pediatric Adverse Drug Events in the Outpatient Setting: An 11-Year National Analysis
    Bourgeois, Florence T.
    Mandl, Kenneth D.
    Valim, Clarissa
    Shannon, Michael W.
    PEDIATRICS, 2009, 124 (04) : E744 - E750
  • [29] Impact of computerized prescriber order entry on the incidence of adverse drug events in pediatric inpatients
    Holdsworth, Mark T.
    Fichtl, Richard E.
    Raisch, Dennis W.
    Hewryk, Adrianne
    Behta, Maryam
    Mendez-Rico, Elena
    Wong, Cindy L.
    Cohen, Jennifer
    Bostwick, Susan
    Greenwald, Bruce M.
    PEDIATRICS, 2007, 120 (05) : 1058 - 1066
  • [30] Pharmacogenetics of pediatric acute lymphoblastic leukemia in Uruguay: adverse events related to induction phase drugs
    Burgueno-Rodriguez, Gabriela
    Mendez, Yessika
    Olano, Natalia
    Schelotto, Magdalena
    Castillo, Luis
    Soler, Ana Maria
    da Luz, Julio
    FRONTIERS IN PHARMACOLOGY, 2023, 14